Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-32194500

ABSTRACT

The insulin-like growth factor (IGF) family plays key roles in growth and development. In the cornea, IGF family members have been implicated in proliferation, differentiation, and migration, critical events that maintain a smooth refracting surface that is essential for vision. The IGF family is composed of multiple ligands, receptors, and ligand binding proteins. Expression of IGF type 1 receptor (IGF-1R), IGF type 2 receptor (IGF-2R), and insulin receptor (INSR) in the cornea has been well characterized, including the presence of the IGF-1R and INSR hybrid (Hybrid-R) in the corneal epithelium. Recent data also indicates that each of these receptors display unique intracellular localization. Thus, in addition to canonical ligand binding at the plasma membrane and the initiation of downstream signaling cascades, IGF-1R, INSR, and Hybrid-R also function to regulate mitochondrial stability and nuclear gene expression. IGF-1 and IGF-2, two of three principal ligands, are polypeptide growth factors that function in all cellular layers of the cornea. Unlike IGF-1 and IGF-2, the hormone insulin plays a unique role in the cornea, different from many other tissues in the body. In the corneal epithelium, insulin is not required for glucose uptake, due to constitutive activation of the glucose transporter, GLUT1. However, insulin is needed for the regulation of metabolism, circadian rhythm, autophagy, proliferation, and migration after wounding. There is conflicting evidence regarding expression of the six IGF-binding proteins (IGFBPs), which function primarily to sequester IGF ligands. Within the cornea, IGFBP-2 and IGFBP-3 have identified roles in tissue homeostasis. While IGFBP-3 regulates growth control and intracellular receptor localization in the corneal epithelium, both IGFBP-2 and IGFBP-3 function in corneal fibroblast differentiation and myofibroblast proliferation, key events in stromal wound healing. IGFBP-2 has also been linked to cellular overgrowth in pterygium. There is a clear role for IGF family members in regulating tissue homeostasis in the cornea. This review summarizes what is known regarding the function of IGF and related proteins in corneal development, during wound healing, and in the pathophysiology of disease. Finally, we highlight key areas of research that are in need of future study.


Subject(s)
Cornea/physiology , Corneal Diseases/etiology , Insulin-Like Growth Factor Binding Proteins/physiology , Insulin-Like Growth Factor I/physiology , Insulins/physiology , Wound Healing/physiology , Animals , Cornea/growth & development , Cornea/pathology , Corneal Diseases/pathology , Corneal Injuries/physiopathology , Humans , Signal Transduction/physiology , Wound Healing/genetics
2.
Med Sci (Paris) ; 33(6-7): 637-641, 2017.
Article in French | MEDLINE | ID: mdl-28990566

ABSTRACT

Body size is an intrinsic property of living organisms that is intimately linked to the developmental program to produce fit individuals with proper proportions. Final size is the result of both genetic determinants and sophisticated mechanisms adapting size to available resources. Even though organs grow according to autonomous programs, some coordination mechanisms ensure that the different body parts adjust their growth with the rest of the body. In Drosophila, Dilp8, a hormone of the Insulin/Relaxin family is a key player in this inter-organs coordination and is required together with its receptor Lgr3 to limit developmental variability. Recently, the transcriptional co-activator Yki (homologue of YAP/TAZ factors in mammals) was shown to regulate dilp8 expression and contribute to the coordination of organ growth in Drosophila.


Subject(s)
Growth and Development , Insulins/physiology , Animals , Drosophila Proteins/genetics , Drosophila Proteins/pharmacology , Drosophila Proteins/physiology , Drosophila melanogaster/genetics , Drosophila melanogaster/growth & development , Gene Expression Regulation, Developmental/drug effects , Growth and Development/drug effects , Growth and Development/genetics , Humans , Insulins/genetics , Insulins/pharmacology , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/pharmacology , Intercellular Signaling Peptides and Proteins/physiology , Signal Transduction/drug effects
3.
Article in Portuguese | MEDLINE | ID: mdl-24646931

ABSTRACT

The hormonal abuse in physical exercise practioners is very common. Many pleople believe these substances can promote skeletal muscle hyperthrophy and improve physical fitness without health damaging effects. However, this is another myth that science unmasked. This article updates information regarding abuse of insulin, growth hormone, thyroid hormones, and erythropoitin. The peptide hormone abuse can cause motor paralysis, skeletal muscle damage and loss, diabetes mellitus, hypothyroidism, arterial hypertension, sweating, headaches, vomiting and enhances the risk for atherosclerosis, thrombosis, osteoporosis, and cancer.


El abuso de hormonas en practicantes de ejercicios físicos es muy difundido. Muchas personas creen que estas sustancias pueden producirla hipertrofia muscular y mejorar el estado físico sin traer daños a la salud. Sin embargo, esto es sólo un mito desacreditado por la ciencia. En este artículo se actualizan las informaciones sobre el abuso de la insulina, hormonas del crecimiento, hormonas tiroideas yeritropoyetina. El abuso de hormonas de la proteína (péptido) puede causar parálisis motora, lesión y pérdida de la masa muscular, la diabetes mellitus, hipotiroidismo, hipertensión arterial, sudoración, dolor de cabeza, vómitos y aumenta el riesgo de arterioesclerosis, trombosis, osteoporosis y cáncer. Palabras-clave: IGF-1, insulina, diabetes, hipertensión, hipotiroidismo.


Subject(s)
Exercise , Peptide Hormones/adverse effects , Sports , Erythropoietin/adverse effects , Erythropoietin/physiology , Exercise/physiology , Growth Hormone/adverse effects , Growth Hormone/physiology , Humans , Insulins/adverse effects , Insulins/physiology , Peptide Hormones/physiology , Sports/physiology , Thyroid Hormones/adverse effects , Thyroid Hormones/physiology
4.
Article in Spanish | BINACIS | ID: bin-132713

ABSTRACT

The hormonal abuse in physical exercise practioners is very common. Many pleople believe these substances can promote skeletal muscle hyperthrophy and improve physical fitness without health damaging effects. However, this is another myth that science unmasked. This article updates information regarding abuse of insulin, growth hormone, thyroid hormones, and erythropoitin. The peptide hormone abuse can cause motor paralysis, skeletal muscle damage and loss, diabetes mellitus, hypothyroidism, arterial hypertension, sweating, headaches, vomiting and enhances the risk for atherosclerosis, thrombosis, osteoporosis, and cancer.


Subject(s)
Exercise , Peptide Hormones/adverse effects , Sports , Erythropoietin/adverse effects , Erythropoietin/physiology , Exercise/physiology , Growth Hormone/adverse effects , Growth Hormone/physiology , Humans , Insulins/adverse effects , Insulins/physiology , Peptide Hormones/physiology , Sports/physiology , Thyroid Hormones/adverse effects , Thyroid Hormones/physiology
5.
Article in Spanish | LILACS, BINACIS | ID: biblio-1170948

ABSTRACT

The hormonal abuse in physical exercise practioners is very common. Many pleople believe these substances can promote skeletal muscle hyperthrophy and improve physical fitness without health damaging effects. However, this is another myth that science unmasked. This article updates information regarding abuse of insulin, growth hormone, thyroid hormones, and erythropoitin. The peptide hormone abuse can cause motor paralysis, skeletal muscle damage and loss, diabetes mellitus, hypothyroidism, arterial hypertension, sweating, headaches, vomiting and enhances the risk for atherosclerosis, thrombosis, osteoporosis, and cancer.


Subject(s)
Sports , Exercise , Peptide Hormones/adverse effects , Erythropoietin/adverse effects , Erythropoietin/physiology , Sports/physiology , Exercise/physiology , Growth Hormone/adverse effects , Growth Hormone/physiology , Peptide Hormones/physiology , Thyroid Hormones/adverse effects , Thyroid Hormones/physiology , Humans , Insulins/adverse effects , Insulins/physiology
6.
Amino Acids ; 43(3): 1131-40, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22855207

ABSTRACT

One of the most recognised and studied family of peptide hormones is the insulin superfamily. Within this family is the relaxin subfamily which comprises seven members: relaxin-1, -2 and -3 and insulin-like peptides 3, 4, 5 and 6. Besides exhibiting sequence similarities, each member exists as an active A-B heterodimer linked by three disulfide bonds. This mini-review is divided into three broad themes: an overview of all insulin superfamily members (including structural similarities); roles of each superfamily member and finally, a focus on the pleiotropic peptide hormone, human relaxin-2. In addition to promoting vasodilatory effects leading to evaluation in Phase III clinical trials for the treatment of acute heart failure, relaxin has recently been shown to be highly expressed by cancer cells, aiding in their proliferation, invasiveness and metastasis. These contrary effects of relaxin are discussed together with current efforts in the development of relaxin antagonists that may possess future therapeutic potential for the treatment of certain cancers.


Subject(s)
Neoplasms/metabolism , Relaxin/metabolism , Amino Acid Sequence , Animals , Antineoplastic Agents/pharmacology , Conserved Sequence , Evolution, Molecular , Humans , Insulins/genetics , Insulins/metabolism , Insulins/physiology , Molecular Sequence Data , Molecular Targeted Therapy , Neoplasms/drug therapy , Neoplasms/pathology , Protein Conformation , Receptors, G-Protein-Coupled/antagonists & inhibitors , Receptors, Peptide/antagonists & inhibitors , Relaxin/genetics , Relaxin/physiology
7.
Rev. argent. endocrinol. metab ; 45(4): 149-161, jul.-sep. 2008. graf
Article in Spanish | LILACS | ID: lil-641940

ABSTRACT

Es conocido que las hormonas esteroideas sexuales modulan la composición corporal y otras funciones endocrinas. El objetivo del presente trabajo fue estudiar el impacto de la administración de esteroides sexuales sobre la insulinosensibilidad periférica y la función secretora adipocitaria. Grupos de ratas hembra recibieron vehículo (C) o valerato de E2 o propionato de T. Se monitoreó el peso corporal y la ingesta de alimento hasta el día experimental, que fueron sacrificados en condición basal o sometidos a un test de sobrecarga con glucosa. Se evaluaron las concentraciones de leptina, E2, T, glucosa, triglicéridos e insulina (INS). Se ponderó el tejido adiposo parametrial y se aislaron los adipocitos e incubaron con o sin INS. E2 indujo una temprana (p < 0,05) hipofagia, contrariamente, T indujo una moderada (p < 0,05) hiperfagia. Los animales E2 resultaron con menor peso y masa adiposa parametrial que los C (p < 0,05). Los niveles plasmáticos no se modificaron en los animales E2 ni T, salvo el desarrollo de hiperleptinemia en el grupo E2 (p < 0,05). El test de tolerancia a la glucosa mostró (p < 0,05) aumento y disminución en la insulinosensibildad en los animales E2 y T, respectivamente. Finalmente, los adipocitos aislados de animales E2 como los T desarrollaron una disminuida (p < 0,05 vs. C) respuesta a INS. Nuestro estudio pone en evidencia los efectos de E2 y T sobre la sensibilidad a insulina y la función adipocitaria.


Sex hormones are known to modulate body composition and endocrine functions. The aim of the present study was to analyze the impact of sexual steroids administration on the outlying insulin-sensibility and adipocyte secretory function. Groups of female rats received either vehicle (C), E2 valerate, or T propionate. Daily food intake and body weight were recorded until sacrifice under basal conditions or after high glucose load test. Plasma concentrations of leptin, E2, T, glucose, triglycerides, and insulin (INS) were evaluated. The parametrial adipose tissue was pondered and adipocytes were isolated and then incubated with or without INS. E2 induced early hypophagia (p< 0,05); contrarily, T induced moderate hyperphagia (p<0,05). Weight and fatty parametrial mass values were lower for E2- than C-treated animals (p<0,05). Plasma levels remained unmodified either for E2 or T groups, though E2 animals developed hyperleptinemia (p<0.05). The high glucose load test showed increased and decreased insulin-sensitivity (p<0.05) in E2 and T groups, respectively. Finally, E2 and T isolated adipocytes were less sensitive to insulin-induced leptin secretion than C cells (p<0.05 vs. C). Our study reveals that E2 and T hormones affect sensibility to insulin as well as adipocyte functions.


Subject(s)
Animals , Female , Rats , Gonadal Steroid Hormones/adverse effects , Gonadal Steroid Hormones/metabolism , Adipocytes/physiology , Insulins/physiology , Body Composition/physiology , Leptin/biosynthesis , Estradiol/chemistry , Endocrine Cells/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...